Dabigatran discontinuation in "real-world" practice among Chinese population

被引：0
|
作者：
Ho, M. H. [1 ]
Cheung, E. [1 ]
Ho, C. W. [1 ]
Tse, H. F. [1 ]
Siu, C. W. [1 ]
机构：
[1] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6232
引用
收藏
页码：1104 / 1104
页数：1
相关论文
共 50 条
  • [31] Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population
    Zeng, Jing-Xin
    Luo, Quan
    Wen, Ju
    Tian, Xin
    Zhou, Xin
    Li, Wei
    Tang, Ya-Ping
    Zhang, San-Quan
    Liu, Wei-Yu
    Zhu, Hui-Lan
    Zhang, Xi-Bao
    CHINESE MEDICAL JOURNAL, 2021, 134 (01) : 117 - 119
  • [32] Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population
    Zeng Jing-Xin
    Luo Quan
    Wen Ju
    Tian Xin
    Zhou Xin
    Li Wei
    Tang Ya-Ping
    Zhang San-Quan
    Liu Wei-Yu
    Zhu Hui-Lan
    Zhang Xi-Bao
    中华医学杂志英文版, 2021, 134 (01) : 117 - 119
  • [33] Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa
    Garbayo-Salmons, Patricia
    Vilarrasa, Eva
    Bassas-Vila, Julio
    Mora-Fernandez, Veronica
    Fuertes, Irene
    Luque-Luna, Mar
    Fornons-Servent, Rosa
    Martin-Ezquerra, Gemma
    Aguayo-Ortiz, Rafael Sergio
    Ceravalls, Joan
    Mollet, Jordi
    Tomas, Alvaro Gomez
    Masferrer, Emili
    Corral-Magana, Oriol
    Matas-Nadal, Clara
    del Estal, Jorge
    Bailon, Diana Fuertes
    Calvet, Joan
    Romani, Jorge
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (01) : 221 - 229
  • [34] Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice A Systematic Review and Meta-Analysis
    Romanelli, Robert J.
    Nolting, Laura
    Dolginsky, Marina
    Kym, Eunice
    Orrico, Kathleen B.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2016, 9 (02): : 126 - 134
  • [35] Clinical outcomes after reversal of dabigatran in daily practice: real-world use of idarucizumab 2015-2019
    Haastrup, S.
    Hellfritzsch, M.
    Nybo, M.
    Hvas, A. M.
    Grove, E. L.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3366 - 3366
  • [36] Informing real-world practice with real-world evidence: the value of PRECIS-2
    Neta, Gila
    Johnson, Karin E.
    BMC MEDICINE, 2018, 16
  • [37] Informing real-world practice with real-world evidence: the value of PRECIS-2
    Gila Neta
    Karin E. Johnson
    BMC Medicine, 16
  • [38] Real-world variability in dabigatran levels in patients with atrial fibrillation: reply
    Chan, N. C.
    Hirsh, J.
    Ginsberg, J. S.
    Eikelboom, J. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (06) : 1168 - 1169
  • [39] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience
    Marwan Sheikh-Taha
    American Journal of Cardiovascular Drugs, 2019, 19 : 59 - 64
  • [40] Real-world variability in dabigatran levels in patients with atrial fibrillation: comment
    Douxfils, J.
    Chatelain, B.
    Dogne, J. -M.
    Mullier, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (06) : 1166 - 1168
12345